|
|
Vaccine Comparison
|
fp-IBD1 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004622
- Type: Recombinant vector vaccine
- Status: Licensed
- Host Species for Licensed Use: Baboon
- Vector:
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
|
|
|
FP-IBDV-VP2 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004742
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- VP2
gene engineering:
- Type: Recombinant vector construction
- Description: A fowlpox virus vector was used to carry the VP2 gene of infectious bursal disease virus (IBDV) fused with β-galactosidase (Butter et al., 2013).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: (Butter et al., 2013) fp-IBD1, which consists of a fowlpox virus vector carrying the VP2 gene of infectious bursal disease virus (IBDV) fused with β-galactosidase.
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Butter et al., 2013: Butter C, Staines K, van Hateren A, Davison TF, Kaufman J. The peptide motif of the single dominantly expressed class I molecule of the chicken MHC can explain the response to a molecular defined vaccine of infectious bursal disease virus (IBDV). Immunogenetics. 2013; 65(8); 609-618. [PubMed: 23644721].
|
|
rFPV-IBDV-VP 2.4.3 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004750
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- VP2-VP4-VP3
gene engineering:
- Type: Recombinant vector construction
- Description: Recombinant FPV-VP 2.4.3 contained the gene for the VP 2-VP4-VP3 polyprotein under the control of the vaccinia virus late promoter P.L 11 inserted within the thymidine kinase (TK) gene of FPV (Heine and Boyle, 1993).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: Recombinant FPV-VP 2.4.3 contained the gene for the VP 2-VP4-VP3 polyprotein under the control of the vaccinia virus late promoter P.L 11 inserted within the thymidine kinase (TK) gene of FPV (Heine and Boyle, 1993).
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Heine and Boyle, 1993: Heine HG, Boyle DB. Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. Archives of virology. 1993; 131(3-4); 277-292. [PubMed: 8394069].
|
|
rFPV-IBDV-VP2 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004625
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Chicken
- VP2
gene engineering:
- Type: Recombinant vector construction
- Description: Marek's disease and Fowlpox viruses expressing the vvIBDV host-protective antigen VP2 (rMDV, rFPV) (Tsukamoto et al., 2000).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: Marek's disease and Fowlpox viruses expressing the vvIBDV host-protective antigen VP2 (rMDV, rFPV) (Tsukamoto et al., 2000).
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Tsukamoto et al., 2000: Tsukamoto K, Sato T, Saito S, Tanimura N, Hamazaki N, Mase M, Yamaguchi S. Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus. Virology. 2000; 269(2); 257-267. [PubMed: 10753704].
|
|
rMDV-IBDV-VP2 |
| Vaccine Information |
- Vaccine Ontology ID: VO_0004749
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- VP2
gene engineering:
- Type: Recombinant vector construction
- Description: IBDV host-protective antigen VP2 was expressed in a recombinant vaccine vector (Tsukamoto et al., 2000).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: Marek's disease and Fowlpox viruses expressing the vvIBDV host-protective antigen VP2 (rMDV, rFPV) (Tsukamoto et al., 2000).
- Immunization Route: Intramuscular injection (i.m.)
|
| References |
Tsukamoto et al., 2000: Tsukamoto K, Sato T, Saito S, Tanimura N, Hamazaki N, Mase M, Yamaguchi S. Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus. Virology. 2000; 269(2); 257-267. [PubMed: 10753704].
|
|
